Source: Critical care. Unidade: FM
Subjects: INSUFICIÊNCIA RENAL AGUDA, TERAPIA DE SUBSTITUIÇÃO RENAL, COVID-19, ANTICOAGULANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALLE, Eduardo de Oliveira et al. Continuous renal replacement therapy in COVID-19-associated AKI: adding heparin to citrate to extend filter life-a retrospective cohort study. Critical care, v. 25, n. 1, 2021Tradução . . Disponível em: https://doi.org/10.1186/s13054-021-03729-9. Acesso em: 27 set. 2024.APA
Valle, E. de O., Cabrera, C. P. S., Albuquerque, C. C. C. de, Silva, G. V. da, Oliveira, M. F. A. de, Sales, G. T. M., et al. (2021). Continuous renal replacement therapy in COVID-19-associated AKI: adding heparin to citrate to extend filter life-a retrospective cohort study. Critical care, 25( 1). doi:10.1186/s13054-021-03729-9NLM
Valle E de O, Cabrera CPS, Albuquerque CCC de, Silva GV da, Oliveira MFA de, Sales GTM, Smolentzov I, Reichert BV, Andrade L da C, Seabra VF. Continuous renal replacement therapy in COVID-19-associated AKI: adding heparin to citrate to extend filter life-a retrospective cohort study [Internet]. Critical care. 2021 ; 25( 1):[citado 2024 set. 27 ] Available from: https://doi.org/10.1186/s13054-021-03729-9Vancouver
Valle E de O, Cabrera CPS, Albuquerque CCC de, Silva GV da, Oliveira MFA de, Sales GTM, Smolentzov I, Reichert BV, Andrade L da C, Seabra VF. Continuous renal replacement therapy in COVID-19-associated AKI: adding heparin to citrate to extend filter life-a retrospective cohort study [Internet]. Critical care. 2021 ; 25( 1):[citado 2024 set. 27 ] Available from: https://doi.org/10.1186/s13054-021-03729-9